Obalon Therapeutics, Inc. OBLN
Set alert
3.05 0.00 0.00%
At close
2.95 Day range 4.80
52-week range unavailable
- Open
- 3.25
- Prev close
- 3.05
- Mkt cap
- 5.47M
- Vol
- 26.47M
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 2.95
- High
- 4.80
- Forward P/E
- -11.30
- Beta
- -1.24
- Short ratio
- 0.08
- Inst. own
- 31.70%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Jul 29, 2021
- 50-d avg
- 9.14
- 200-d avg
- 9.08
- 1y target
- 6.15
Analyst view
Consensus: buy
Buy
Price target (mean) 6.15
Ratings (0m) 5 4 buy · 0 hold · 1 sell
- Strong buy3
- Buy1
- Hold0
- Sell1
- Strong sell0
Recommendation trend
- This month 5
- 1 month ago 1
- 2 months ago 1
- 3 months ago 5
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current year | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 0 | 0.0% | 0 |
| Next year | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 20.62M | 0.0% | 0 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 25, 2020 | Canaccord Genuity | Downgrade | Buy | Hold |
| Nov 25, 2020 | Roth Capital | Downgrade | Buy | Neutral |
| Nov 25, 2020 | Stifel Nicolaus | Upgrade | Hold | Buy |
| Nov 25, 2020 | Stifel Nicolaus | Maintained | Hold | Hold |
| Nov 25, 2020 | Roth Capital | Initiated | — | Buy |
| Nov 25, 2020 | Stifel Nicolaus | Maintained | Hold | Hold |
| Nov 25, 2020 | Northland Securities | Upgrade | Underperform | Market Perform |
| Nov 25, 2020 | Stifel Nicolaus | Downgrade | Buy | Hold |
| Nov 25, 2020 | Northland Securities | Downgrade | Market Perform | Underperform |
| Nov 25, 2020 | Northland Securities | Upgrade | Underperform | Market Perform |
| Nov 25, 2020 | UBS | Maintained | — | Buy |
| Nov 25, 2020 | Stifel Nicolaus | Initiated | — | Buy |